Alcon bought Aerie Pharmaceuticals Aerie Pharmaceuticals from 11/22/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Alcon completed its acquisition of Aerie Pharmaceuticals for $770 million, or 15.25 per share.

Aerie Pharmaceuticals

Review

Source:

{source} pictogram

investor.alcon.com

Vladimir Petenev

News editor

Write your comment first

News feed

Polymetal shareholders approve share swap for Russian holders

12/11/23 POLY

Severstal has found a supplier of equipment for pellet production

12/8/23 CHMF

Yandex became one of the world leaders in the field of AI development

12/8/23 YNDX

Kamaz shared its plans for 2024

12/8/23 KMAZ

MTS launched beta testing of Nuum video platform

12/8/23 MTSS

VTB decided to become an oil trader

12/8/23 VTBR

VK gets acquainted with the Belarusian IT community

12/8/23 VKCO

VTB intends to enter the segment of brokerage services for legal entities

12/8/23 VTBR

Moscow Exchange is developing a bookbuilding system

12/8/23 MOEX

Novatek may first send gas via the Northern Sea Route in January-April

12/8/23 NVTK